arrow
返回
P

Paul M. Barr

university of rochester

53H指数
451论文数
1.6W被引数
收录论文 69
发表时间
Nivolumab plus brentuximab vedotin for relapsed/refractory diffuse large B-cell lymphoma纳武利尤单抗联合 Brentuximab Vedotin 治疗复发/难治性弥漫性大B细胞淋巴瘤
err2025-12-10
err0
errOAAI
errNathalie A. Johnson; Pier Luigi Zinzani; Eva Domingo-Domenech; Joshua Brody; Justin Kline; Bijal Dinesh Shah; Amitkumar Nitinkumar Mehta; Herve Ghesquieres; Kerry J. Savage; Paul M. Barr; Armando Santoro; Silvia Ferrari; David Cunningham; Graham P. Collins; Michelle Fanale; Jennifer Krajewski; Alev Akyol; Russell Crowe; Rachael Wen; John Kuruvilla
err分享
err收藏
Functional genomics and tumor microenvironment analysis reveal prognostic biological subtypes in Mantle cell lymphoma功能基因组学和肿瘤微环境分析揭示了套细胞淋巴瘤中的预后生物学亚型
err2025-11-05
err0
errOAAI
errSunandini Sharma; Roshia Ali; Alyssa Bouska; Dylan Jochum; Meghana Kesireddy; Simeon Mahov; Joseph Lownik; Weiwei Zhang; Waseem Lone; Mahfuza Afroz Soma; Alicia Gamboa; Vaishnavi Devarakonda; Dalia El-Gamal; Atqiya Fariha; Adnan Mansoor; Douglas Stewart; Peter Martin; Brian K. Link; Ranjana H. Advani; Paul M. Barr; Andre H. Goy; Amitkumar Mehta; Manali Kamdar; Deborah M. Stephens; Veronika Bachanova; Lynette Smith; Ryan Morin; Prasath Pararajalingam; Matthew A. Lunning; Kai Fu; Dennis Weisenburger; Wing C. Chan; Joseph Khoury; Timothy C. Greiner; Julie M. Vose; Akil Merchant; Chengfeng Bi; Javeed Iqbal
err分享
err收藏
Intravenous low-dose anti-CD20 Rituximab infusion contrasted with subsequent subcutaneous Rituximab injection during CLL patient treatment
err2025-11-01
err0
PREAI
errChu, Charles C.; Heffernan, Clare B.; Bruno, Jennifer E.; Herne, Christine A.; Jaimes-Delgadillo, Nydia; Baran, Andrea M.; Barr, Paul M.; Elliott, Michael Rusty; Zent, Clive S.
err分享
err收藏
Final analysis of the RESONATE-2 study: up to 10 years of follow-up of first-line ibrutinib treatment for CLL/SLLRESONATE-2研究的最终分析:ibrutinib作为CLL/SLL患者一线治疗长达10年的随访研究
errBlood
IF23.1
err2025-08-05
err0
errOAAI
errJan A. Burger; Paul M. Barr; Tadeusz Robak; Carolyn Owen; Alessandra Tedeschi; Anita Sarma; Piers E. M. Patten; Sebastian Grosicki; Helen McCarthy; Fritz Offner; Edith Szafer-Glusman; Cathy Zhou; Anita Szoke; Lynne Neumayr; James P. Dean; Paolo Ghia; Thomas J. Kipps
err分享
err收藏
Feasibility of Bruton’s Tyrosine Kinase Inhibitor Discontinuation in Chronic Lymphocytic Leukemia: The Patient PerspectiveBruton’s Tyrosine Kinase 抑制剂停药在慢性淋巴细胞白血病中的可行性:患者的视角
err2025-05-16
err0
PREAI
errDeborah M. Stephens; Chris Stewart; Liza Avruch; Catherine C. Coombs; Alexey Danilov; Brian Hill; Mazyar Shadman; Alina Gerrie; Christopher E. Jensen; Marc Hoffmann; Allison Winter; Daniel A. Ermann; Paul M. Barr; Susan O’Brien; Brian Koffman; John C. Byrd
err分享
err收藏
Treatment Effectiveness of Venetoclax-Based Therapy After Bruton Tyrosine Kinase Inhibitors in Chronic Lymphocytic Leukemia: An International Real-World Study布鲁顿酪氨酸激酶抑制剂治疗慢性淋巴细胞白血病后基于维尼托克的治疗效果: 一项国际真实世界研究
err2024-12-19
err0
errOAAI
errGhosh, Nilanjan; Eyre, Toby A.; Brown, Jennifer R.; Lamanna, Nicole; Manzoor, Beenish S.; Coombs, Catherine C.; Tuncer, Hande H.; Ujjani, Chaitra; Leslie, Lori A.; Roeker, Lindsey E.; Davids, Matthew S.; Rhodes, Joanna M.; Skarbnik, Alan P.; Sinai, Wendy; Fleury, Isabelle; Hill, Brian T.; Martinez-Calle, Nicolas; Barr, Paul M.; Jawaid, Dureshahwar; Emechebe, Nnadozie; Pearson, Laurie; Lansigan, Frederick; Choi, Yun; Jensen, Christopher E.; Fakhri, Bita; Stephens, Deborah M.; Marx, Steven E.; Schuster, Stephen J.; Coyle, Michael; Pivneva, Irina; Watson, Talissa; Guerin, Annie; Shadman, Mazyar
err分享
err收藏
Vitamin D in patients with low tumor-burden indolent non- Hodgkin lymphoma treated with rituximab therapy (ILyAD): a randomized, phase 3 clinical trial
err2024-12-01
err1
errOAAI
errFriedberg, Jonathan W.; Brady, Michael T.; Strawderman, Myla; Kahl, Brad S.; Lossos, Izidore S.; Cohen, Jonathon B.; Reagan, Patrick M.; Casulo, Carla; Averill, Barbara L.; Baran, Andrea; Sutamtewagul, Grerk; Barr, Paul M.; Leonard, John P.; Ashton, John M.; Strang, John G.; Vega, Francisco; Peterson, Derick R.; Nastoupil, Loretta J.
err分享
err收藏
Feasibility of Discontinuation of Bruton's Tyrosine Kinase Inhibitors in Patients with Chronic Lymphocytic Leukemia: A Patient Survey慢性淋巴细胞白血病患者停用布托替尼酪氨酸激酶抑制剂的可行性:一项患者调查
errBLOOD
IF23.1
err2024-11-05
err0
PREAI
errStephens, Deborah M.; Stewart, Chris; Avruch, Liza; Coombs, Catherine C.; Danilov, Alexey; Hill, Brian T.; Shadman, Mazyar; Gerrie, Alina S.; Jensen, Christopher E.; Hoffmann, Marc; Winter, Allison M.; Ermann, Daniel A.; Barr, Paul M.; O'Brien, Susan M.; Koffman, Brian; Byrd, John C.
err分享
err收藏
First-line ibrutinib treatment in patients with chronic lymphocytic leukemia is associated with overall survival rates similar to those of an age-matched general population: A pooled post hoc analysis
err2024-05-27
err0
errOAAI
errGhia, Paolo; Owen, Carolyn; Allan, John N.; Barrientos, Jacqueline C.; Barr, Paul M.; Shi, Chunxue; Szoke, Anita; Abbazio, Christopher; Krigsfeld, Gabriel S.; Burger, Jan A.
err分享
err收藏
Nivolumab plus brentuximab vedotin for relapsed/refractory peripheral T-cell lymphoma and cutaneous T-cell lymphomaNivolumab联合brentuximab vedotin治疗复发/难治性外周T细胞淋巴瘤和皮肤T细胞淋巴瘤
err2024-05-20
err1
errOAAI
errZinzani, Pier Luigi; Salles, Gilles; Moskowitz, Alison J.; Santoro, Armando; Mehta, Amitkumar; Barr, Paul M.; Mehta-Shah, Neha; Collins, Graham P.; Ansell, Stephen M.; Brody, Joshua D.; Domingo-Domenech, Eva; Johnson, Nathalie A.; Cunningham, David; Ferrari, Silvia; Lisano, Julie; Krajewski, Jennifer; Wen, Rachael; Akyol, Alev; Crowe, Russell; Savage, Kerry J.
err分享
err收藏
Integrative analysis of clinicopathological features defines novel prognostic models for mantle cell lymphoma in the immunochemotherapy era: a report from The North American Mantle Cell Lymphoma Consortium
err2023-12-16
err2
errOAAI
errVose, Julie M.; Fu, Kai; Wang, Lu; Mansoor, Adnan; Stewart, Douglas; Cheng, Hongxia; Smith, Lynette; Yuan, Ji; Qureishi, Hina Naushad; Link, Brian K.; Cessna, Melissa H.; Barr, Paul M.; Kahl, Brad S.; Mckinney, Matthew S.; Khan, Nadia; Advani, Ranjana H.; Martin, Peter; Goy, Andre H.; Phillips, Tycel J.; Mehta, Amitkumar; Kamdar, Manali; Crump, Michael; Pro, Barbara; Flowers, Christopher R.; Jacobson, Caron A.; Smith, Sonali M.; Stephens, Deborah M.; Bachanova, Veronika; Jin, Zhaohui; Wu, Shishou; Hernandez-Ilizaliturri, Francisco; Torka, Pallawi; Anampa-Guzman, Andrea; Kashef, Farshid; Li, Xing; Sharma, Sunandini; Greiner, Timothy C.; Armitage, James O.; Lunning, Matthew; Weisenburger, Dennis D.; Bociek, Robert G.; Iqbal, Javeed; Yu, Guohua; Bi, Chengfeng
err分享
err收藏
ALK-rearranged CD30-positive poorly differentiated lung adenocarcinoma, mimicking anaplastic large-cell lymphomaALK重排CD30-positive低分化肺腺癌,模仿间变性大细胞淋巴瘤
err2023-11-30
err0
errOAAI
errGeorge, Giby, V; Wallace, Danielle S.; Wang, Ying; Carney, John; Elsadawi, Murad; Burack, W. Richard; Evans, Andrew G.; Barr, Paul M.; Velez, Moises J.; El Hussein, Siba
err分享
err收藏
Outcomes of limited stage primary bone diffuse large B-cell lymphoma in the rituximab era: a multicenter, retrospective study
err2023-10-19
err3
errOAAI
errRezazadeh, Alexandra; Szabo, Aniko; Khurana, Arushi; Inwards, David J.; Lunning, Matthew A.; Bartlett, Nancy L.; Caimi, Paolo F.; Rodgers, Thomas D.; Barr, Paul M.; Chowdhury, Sayan Mullick; Epperla, Narendranath; Mendries, Hiruni; Hill, Brian T.; Oh, Timothy S.; Karmali, Reem; Chang, Julie E.; Goyal, Gaurav; Parsons, Benjamin M.; Isaac, Krista M.; Portell, Craig A.; Monahan, Kathleen; Siker, Malika; King, David M.; Fenske, Timothy S.
err分享
err收藏
Nivolumab combined with brentuximab vedotin for R/R primary mediastinal large B-cell lymphoma: a 3-year follow-upNivolumab联合brentuximab vedotin治疗R/R原发性纵隔大b细胞淋巴瘤: 3年随访
err2023-09-13
err13
errOAAI
errZinzani, Pier Luigi; Santoro, Armando; Gritti, Giuseppe; Brice, Pauline; Barr, Paul M.; Kuruvilla, John; Cunningham, David; Kline, Justin; Johnson, Nathalie A.; Mehta-Shah, Neha; Lisano, Julie; Wen, Rachael; Akyol, Alev; Moskowitz, Alison J.
err分享
err收藏
Outcomes in Patients with High-Risk Features after Fixed-Duration Ibrutinib plus Venetoclax: Phase II CAPTIVATE Study in First-Line Chronic Lymphocytic Leukemia
err2023-06-07
err13
errOAAI
errAllan, John N.; Flinn, Ian W.; Siddiqi, Tanya; Ghia, Paolo; Tam, Constantine S.; Kipps, Thomas J.; Barr, Paul M.; Camburn, Anna Elinder; Tedeschi, Alessandra; Badoux, Xavier C.; Jacobs, Ryan; Kuss, Bryone J.; Trentin, Livio; Zhou, Cathy; Szoke, Anita; Abbazio, Christopher; Wierda, William G.
err分享
err收藏
Acalabrutinib and high-frequency low-dose subcutaneous rituximab for initial therapy of chronic lymphocytic leukemia
err2023-06-02
err5
errOAAI
errWallace, Danielle S.; Zent, Clive S.; Baran, Andrea M.; Reagan, Patrick M.; Casulo, Carla; Rice, Geoffrey; Friedberg, Jonathan W.; Barr, Paul M.
err分享
err收藏
First dose infusion reaction during anti-CD20 monoclonal antibody therapy in chronic lymphocytic leukemia associates with high IP-10 levels amid cytokine release syndrome
err2023-05-01
err0
errOAAI
errChu, Charles C.; Moore, Jeremiah E.; Bloom, Paige C.; Bruno, Jennifer E.; Quataert, Sally A.; Mosmann, Tim R.; Jaimes-Delgadillo, Nydia; Herne, Christine Ann; VanDerMeid, Karl R.; Baran, Andrea M.; Peterson, Derick R.; Taylor, Ronald P.; Elliott, Michael Rusty; Wallace, Danielle S.; Barr, Paul M.; Zent, Clive S.
err分享
err收藏
A phase 1b study of ibrutinib in combination with obinutuzumab in patients with relapsed or refractory chronic lymphocytic leukemia
errLEUKEMIA
IF13.4
err2023-01-30
err3
errOAAI
errRyan, Christine E.; Brander, Danielle M.; Barr, Paul M.; Tyekucheva, Svitlana; Hackett, Liam R.; Collins, Mary C.; Fernandes, Stacey M.; Ren, Yue; Zhou, Yinglu; McDonough, Mikaela M.; Walker, Heather A.; McEwan, Monica R.; Abramson, Jeremy S.; Jacobsen, Eric D.; LaCasce, Ann S.; Fisher, David C.; Brown, Jennifer R.; Davids, Matthew S.
err分享
err收藏